Analyst Report: ARES
1. EXECUTIVE SUMMARY
Ares Management Corporation (ARES) shares plummeted -6.97% on February 23, 2026, caught in a violent sector-wide selloff triggered by distress at competitor Blue Owl Capital. The immediate catalyst was Blue Owl’s decision to freeze redemptions on a private credit fund, which ignited fears of a liquidity crisis across the alternative asset management industry. This panic was compounded by a growing market narrative that artificial intelligence (AI) could disrupt the software companies that make up a significant portion of private credit loan portfolios. While Ares’ underlying fundamentals remain intact, the stock is currently suffering from contagion risk and negative sentiment toward the "private credit bubble" thesis.
2. THE CATALYST (CRITICAL)
Primary Trigger: Contagion from Blue Owl Capital (OWL) Redemption Freeze
- Event: On/around February 23, reports circulated that competitor Blue Owl Capital had frozen redemptions on a $1.7 billion unlisted private credit fund. This sparked fears of a "run on the bank" scenario for illiquid private credit vehicles.
- Secondary Trigger: "AI Disruption" Narrative in Software Lending. Investors are increasingly concerned that the software sector—a massive borrower base for private credit firms like Ares—faces existential risk from AI automation. This "software apocalypse" fear is driving a repricing of credit risk for lenders heavily exposed to tech.
- Market Context: A broader "risk-off" day on Feb 23, driven by new tariff announcements and geopolitical tensions, exacerbated the move, dragging down the entire financial sector.
3. COMPANY PROFILE
- Official Name: Ares Management Corporation
- Ticker: ARES (NYSE)
- Core Business: A leading global alternative investment manager operating across Credit, Private Equity, Real Estate, and Infrastructure. They are a dominant player in Private Credit (Direct Lending), providing financing to middle-market companies.
- Market Cap: ~$40 Billion
- Key Competitors: Blue Owl Capital (OWL), Blackstone (BX), Apollo Global Management (APO), KKR & Co (KKR).
- Performance Context:
- 24h Change: -6.97%
- YTD Performance: Down ~19-20%
- 52-Week Range: $110.63 - $195.26 (Currently trading near 52-week lows)
4. DEEP DIVE ANALYSIS
Systemic Fear vs. Idiosyncratic Risk: The drop in ARES is a classic "sympathy move." Unlike Blue Owl, Ares has not announced a redemption freeze or a specific liquidity crisis. However, because Ares is a bellwether for the private credit industry, it is being punished by the market’s sudden reassessment of the asset class's liquidity profile.
The "AI Risk" in Credit Portfolios: Ares (and its BDC subsidiary Ares Capital, ARCC) has significant exposure to the software and services sector. The bear case gaining traction is that Generative AI will displace legacy software providers (SaaS), leading to increased defaults among the borrowers in Ares' portfolio. Until Ares can demonstrate that its loan book is resilient to this technological shift, the stock will likely trade with a "tech disruption" discount.
Fundamentals vs. Sentiment:
- Bear Case: The "Golden Age of Private Credit" is ending. Higher-for-longer rates combined with AI disruption will cause a spike in defaults. Liquidity mismatches in semi-liquid funds could force fire sales.
- Bull Case: This is an overreaction. Ares has a diverse, senior-secured portfolio and rigorous underwriting. The distress at Blue Owl is specific to their retail-facing fund structure. Ares recently raised a record $113 billion in 2025, showing institutional confidence remains high.
5. TECHNICAL SNAPSHOT
- Current Price: ~$115.79 (Intraday low of $114.92 on Feb 23)
- Support Levels: Critical support sits at $110.63 (the 52-week low). A break below this level would put the stock in "no man's land" technically, potentially targeting psychological support at $100.
- Resistance: Immediate resistance at $123-125 (previous support turned resistance).
- Volume: Selling occurred on elevated volume, confirming strong institutional distribution and panic selling.
- Pattern: The stock is in a steep downtrend, trading well below its 50-day and 200-day moving averages. The chart depicts a "falling knife" scenario.
6. RISK FACTORS
- Liquidity Contagion: If more private credit funds (including Ares') gate redemptions, panic will intensify.
- Credit Quality Deterioration: Any uptick in non-accruals (defaults) in Ares’ Q1 2026 earnings would validate the "AI disruption" fears.
- Regulatory Scrutiny: The troubles in the sector could invite SEC or FSOC intervention, leading to tighter capital requirements.
- Insider Selling: Recent Form 4 filings show insiders (e.g., General Counsel) selling shares in February, which does not inspire confidence during a drawdown.
7. ACTIONABLE OUTLOOK
- Short-Term (1-2 Weeks): Avoid / High Volatility. Expect continued choppiness. The stock may test the $110 support level. Do not try to "catch the falling knife" until the Blue Owl news cycle stabilizes.
- Medium-Term (1-3 Months): Watch for Stabilization. Monitor monthly fund flows and any intra-quarter updates from management. If Ares confirms their liquidity remains robust and redemptions are normal, a relief rally back to $130-$140 is likely.
- Long-Term Thesis: Intact but Repriced. Ares remains a best-in-class operator. If the "private credit bubble" fears prove exaggerated, the current valuation (~$115) represents a compelling entry point for patient capital, but the "easy money" era for the sector is likely over.